期刊文献+

血清1,5-脱水葡萄糖醇——新疆地区2型糖尿病视网膜病变的危险因素 被引量:2

1,5-anhydroglucitol:a risk factor of retinopathy in patients with type 2 diabetes mellitus in Xinjiang autonomous region
下载PDF
导出
摘要 目的探讨血清1,5-脱水葡萄糖醇(1,5-AG)是否为新疆地区糖尿病视网膜病变(DR)的危险因素。方法收集2012-2014年在新疆医科大学第一附属医院门诊就诊的2型糖尿病(T2DM)患者556例,分为DR组和非DR组,检测两组患者血清1,5-AG、糖化血红蛋白(HbA4c)、随机血糖(RBG)、血尿素氮(BUN)、尿酸(UA)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)和肌酐(cr)等生物化学指标。结果两组间的年龄,性别和民族构成,以及有无T2DM家族史和心脑血管病史的差异均无统计学意义(P值均〉0.05);DR组患者的T2DM病程显著长于非DR组(P〈0.01),有高血压史患者的构成比显著高于非DR组(P〈0.01)。DR组患者的血清1,5-AG水平显著低于非DR组(P〈0.05)。DR组患者的胱抑素C(CysC)、RBG、果糖胺(FMN)和HbA4c水平均显著高于非DR组(P值分N〈0.05、0.01)。在新疆地区T2DM人群中,性别、民族、T2DM家族史、心脑血管病史、年龄,以及FMN、CysC、RBG水平与DR发病均不相关(P值均〉0.05);高血压史(OR=4.137,95%CI为1.44911.810)、HbA1c(OR=1.582,95%CI为1.155-2.167)、T2DM病程(OR=1.736,95%CI为1.545-4.838)和血清1,5-AG水平(OR=0.981,95%CI为0.969-0.993)均与DR发病相关(P值均〈0.01)。血清1,5-AG水平的R0c的AUC为0.712,阳性界值为76.40,灵敏度和特异度分别为71.4%和60.7%。结论高血压史、Hb&c、T2DM病程和血清1,5-AG水平与DR发病密切相关,血清1,5-AG可作为新疆地区DR发生的危险因素。 Objective To explore whether 1,5-anhydroglucitol (1,5-AG) is a risk factor of diabetic retinopathy (DR) in Xinjiang autonomous region. Methods A total of 556 outpatients with type 2 diabetes mellitus (T2DM) visiting our hospital from 2012 to 2014 were divided into DR group and non-DR group. Serum 1,5-AG, glycosylated hemoglobin (HbAlc), random blood glucose (RBG), blood urea nitrogen (BUN), uric acid (UA), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), triglycerides (TC), creatinine (Cr) and other indicators were tested. Results There were no significant differences in terms of gender, age, nationality, family history of T2DM, or cardio-cerebrovascular disease history between two groups (all P〈0.05). There were more patients with hypertension history and patients had a longer T2DM duration in DR group than non-DR group (both P〈0.01). Serum 1,5-AG in DR group was significantly lower than that in non-DR group ( P〈0.05), while the levels of cystatin C (CysC), RBG, fructosamine (FMN) and HbA1c in DR group were significantly higher than those in non-DR group (P〈0.05, 0.01). Gender, nationality, family history, cardiocerebrovascular disease history, age, and the levels of FMN, CysC and RBG were not associated with DR (all P〉0. 05), while hypertension history ( OR = 4. 137,95 % CI = 1. 449 - 11.810), HbA1 c ( OR = 1. 582,95 % CI = 1. 155-11.2. 167), T2DM duration (OR =2. 736,95% CI = 1. 545-4. 838) and 1,5-AG level were significantly associated with DR in Logistic regression analysis (all P〈0. 01). The area under the ROC curves of serum 1,5-AG ( OR = 0.981,95 % CI = 0. 969 - 0. 993) was 0.712, with the sensitivity being 71.4 %, specificity being 60.7% and positive value being 76.40. Conclusion There are close correlation between DR and hypertension history, HbA1c, T2DM duration, serum 1,5-AG. Serum 1,5-AG may be considered as a risk factor of DR in Xinjiang autonomous region.
出处 《上海医学》 CAS CSCD 北大核心 2015年第4期323-326,共4页 Shanghai Medical Journal
基金 国家高技术研究发展计划(863计划)资助项目(2011AA02A111)
关键词 血清1 5-脱水葡萄糖醇 糖尿病视网膜病变 风险因素 Seruml,5-anhydroglucitol Diabetic retinopathy Risk factor
  • 相关文献

参考文献17

  • 1SINGH R, RAMASAMY K, ABRAHAM C, et al. Diabetic retinopathy: an update[J]. Indian J Ophthalmol, 2008, 56(3): 178-188.
  • 2DWORACKA M, WINIARSKA H, SZYMANSKA M, et al. 1, 5-anhydro-D-glucitol: a novel marker of glucose excursions[J]. Int J Clin Pract Suppl, 2002, (129) : 40-44.
  • 3方京冲,史虹莉,杨秀芳,沈稚舟,朱禧星.一种新的糖代谢监测指标——血清1,5-脱水山梨醇[J].中华内分泌代谢杂志,1998,14(3):175-179. 被引量:8
  • 4American Diabetes Association. Standards of medical care in diabetes-2012[J]. Diabetes Care, 2012, 35 (Suppl 1): S11-S63.
  • 5WILKINSON C P, FERRIS F L 3rd, KLEIN R E, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales [ J ]. Ophthalmology, 2003, 110(9) : 1677-1682.
  • 6COLLINS A J, KASISKE B, HERZOG C, et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States[J]. Am J Kidney Dis, 2005, 45(Suppl 1) : A5-AT, S1-S280.
  • 7DWORACKA M, WINIARSKA H, KUCZYNSKI S. The association between glycoxidation and chronic or acute hyperglycaemia in type 2 diabetic patients with retinopathy [J]. Int J Diabetes Metab, 2006, 14(1): 27-31.
  • 8YAU J W, ROGERS S L, KAWASAKI R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35(3): 556-564.
  • 9沈莹,陈玲,陆雷群.2型糖尿病视网膜病变的相关因素分析[J].上海医学,2009,32(12):1120-1121. 被引量:6
  • 10何斌斌,魏丽,韩俊峰,李鸣,刘宇翔,包玉倩,贾伟平.2型糖尿病患者视网膜病变与贫血的关系[J].上海医学,2012,35(1):20-22. 被引量:11

二级参考文献17

  • 1何进才,莫其农,周小梅,李秀玉,冯玉丽,龙新生.血清1,5脱水葡糖醇和果糖胺对糖尿病诊断的评价[J].中国误诊学杂志,2004,4(4):497-499. 被引量:3
  • 2孙文涛,张小玲,高嵩.糖尿病性视网膜病变发生发展的相关因素[J].国际眼科杂志,2005,5(4):755-759. 被引量:43
  • 3陆雷群,陈玲,孙慧芳,郁忠勤,王宇森.高同型半胱氨酸血症对2型糖尿病血管损伤的影响[J].上海医学,2006,29(8):579-580. 被引量:1
  • 4ALMOZNINO-SARAFIAN D,SHTEINSHNAIDER M,TZUR I,et al.Anemia in diabetic patients at an internal medicine ward:clinical correlates and prognostic significance[J].Eur J Intern Med,2010,21(2):91-96.
  • 5MEHDI U,TOTO R D.Anemia,diabetes,and chronic kidney disease[J].Diabetes Care,2009,32(7):1320-1326.
  • 6THOMAS M C,MACISAAC R J,TSALAMANDRIS C,et al.Unrecognized anemia in patients with diabetes:a cross-sectional survey[J].Diabetes Care,2003,26(4):1164-1169.
  • 7DAVIS M D,FISHER M R,GANGNON R E,et al.Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss:Early Treatment Diabetic Retinopathy Study Report#18[J].Invest Ophthalmol Vis Sci,1998,39(2):233-252.
  • 8QIAO Q,KEINNEN-KIUKAANNIEMI S,LAARAE.The relationship between hemoglobin levels and diabetic retinopathy[J].J Clin Epidemiol,1997,50(2):153-158.
  • 9FRIEDMAN E A,L’ESPERANCE F A,BROWN C D,et al.Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease[J].Kidney Int Suppl,2003,(87):S57-S63.
  • 10INABA M,OKUNO S,KUMEDA Y,et al.Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes:effect of anemia and erythropoietin injection[J].J Am Soc Nephrol,2007,18(3):896-903.

共引文献28

同被引文献69

  • 1刘蕾,张维,季学磊.血清25-羟胆骨化醇水平对T2DM患者视网膜病变及糖尿病肾病发生风险的影响[J].哈尔滨医科大学学报,2020(4):387-391. 被引量:3
  • 2李伟,向红丁.北京地区糖尿病性视网膜病变流行病学调查及相关因素分析[J].医学研究通讯,2004,33(6):42-43. 被引量:5
  • 3高翔.糖尿病视网膜病变发生的相关危险因素分析[J].眼科研究,2003,21(3):299-301. 被引量:75
  • 4Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan[J]. Diabetes Care, 2003, 26 (8): 2345-52.
  • 5Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 Diabetologia, diabetes: a nativ nwidervey in Japan [J]. Diabetes Care, 2003, 26(5): 2345-52.
  • 6Beard HA, Alghatrif M, Samper-Tement R, et al. American diabetes association, standards of medical care in diabetes[J]. Diabetes Care, 2012, 35(3): S11-61.
  • 7Cbiou CC, Chung WH, Hung SI, et ai. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection[J]. J Am Acad Dermatol, 2006, 54(2 Suppl): S14-7.
  • 8Yamanouchi T, Tachibana Y, Akanuma H, et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body~J~. Am J Physiol, 1992, 263(2 Pt 1): E268-73.
  • 9Yamanouchi T, Akanuma H, Nakamura T, et al. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients[J]. Diabetologia, 1988, 31(1): 41-5.
  • 10Yamanouchi T, Ogata N, Tagaya T, et al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control [J]. Lancet, 1996, 347(914): 1514-8.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部